Φορτώνει......
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial
The first-in-human phase 1 clinical radioimmunotherapy (RIT) trial with (212)Pb-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane-trastuzumab ((212)Pb-TCMC-trastuzumab) was completed in October 2014 as a joint effort at the University of Alabama (UAB) and the University of Californi...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pharmaceuticals (Basel) |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588176/ https://ncbi.nlm.nih.gov/pubmed/26230702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8030435 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|